< Back to previous page

Patent

Cancer regression by inducing a regeneration-like response

The invention relates to the field of oncology, in particular to the field of anti-cancer agents or mechanisms. In particular, activation of a regeneration-like response, such as by activating expression and/or function of YAP and/or TAZ in an organ carrying a tumor or cancer is capable of causing regression of that tumor or cancer.
Patent Publication Number: WO2020115039
Year filing: 2020
Year approval: 2021
Year publication: 2020
Status: Requested
Technology domains: Pharmaceuticals
Validated for IOF-key: Yes
Attributed to: Associatie KULeuven